Merck and mantro GmbH have established EdiMembre, Massachusetts, U.S.A., a Deep Tech spin-out in the alternative protein industry
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
_256_384.jpg)
Protein-bound Paclitaxel is indicated for the treatment of metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and metastatic adenocarcinoma of the pancreas
This strategic move aims to address the increasing global demand for biologics, enhancing ProBioGen's ability to support partners from cell line development t
This facility marks a significant milestone in transforming the global food industr
Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
Subscribe To Our Newsletter & Stay Updated
